蓝帆医疗 (002382.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(蓝帆医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,648,761,825.111,550,746,520.171,454,848,751.061,342,699,717.791,322,434,033.081,167,746,637.971,094,194,474.12
 营业收入(元) 1,648,761,825.111,550,746,520.171,454,848,751.061,342,699,717.791,322,434,033.081,167,746,637.971,094,194,474.12
二、营业总成本(元) 1,694,564,556.781,606,241,688.531,565,054,500.141,543,222,421.301,436,868,223.761,326,012,671.011,254,659,083.12
 营业成本(元) 1,336,375,681.651,277,259,980.871,241,542,057.871,212,354,501.251,118,909,569.661,035,675,336.00954,057,593.95
 研发费用(元) 80,561,735.8681,648,438.9183,148,650.1663,723,443.3789,848,030.9265,848,965.0671,330,456.77
 营业税金及附加(元) 10,028,618.0410,971,176.8711,131,314.309,870,547.118,637,369.838,296,193.279,522,201.07
 销售费用(元) 111,866,982.58122,328,135.8292,981,661.31130,486,908.93112,409,199.23114,977,589.8490,910,850.58
 管理费用(元) 85,312,946.2181,263,428.4474,006,244.44110,029,059.1374,301,419.2585,516,925.1469,798,416.04
 财务费用(元) 70,418,592.4432,770,527.6262,244,572.0616,757,961.5132,762,634.8715,697,661.7059,039,564.71
  其中:利息费用(元) 74,700,066.4875,376,477.3656,115,310.4748,779,060.1042,073,978.9952,891,258.5138,507,416.04
  其中:利息收入(元) 6,929,709.817,801,033.066,080,089.179,133,635.82-2,758,637.7513,249,832.866,637,607.84
 资产减值损失(元) -2,836,790.091,166,691.57-13,675,578.49-16,024,418.97-16,400,656.70-8,233,365.52-31,597,662.76
 信用减值损失(元) -1,490,229.47-8,541,722.66-5,612,265.06-2,599,530.65-9,030,366.16-9,476,054.49-346,584.99
三、其他经营收益
 加:公允价值变动收益(元) -41,425.4046,152.42-11,134.84-538,684.4046,364.53-867,767.4971,988,379.25
 加:投资收益(元) -489,567.38-2,915,491.92-4,316,708.96-7,538,730.025,715,888.639,402,967.776,827,686.29
  其中:对联营企业和合营企业的投资收益(元) -583,210.92-3,016,942.69-4,546,012.43-2,149,241.76-2,429,454.764,604,229.704,412,928.98
 资产处置收益(元) -364,326.62-13,646.5317,914.71-1,698,236.31-47,842.05109,760.24-286,571.18
 其他收益(元) 3,743,075.634,875,878.0513,401,212.0613,593,452.153,431,282.066,261,000.1216,151,114.67
四、营业利润(元) -47,281,995.00-60,877,307.43-120,402,309.66-215,328,851.71-130,719,520.37-161,069,492.41-97,728,247.72
 加:营业外收入(元) 511,737.14-153,559.7518,406,650.212,713,605.05-1,995,451.293,837,559.475,197,284.31
 减:营业外支出(元) 1,170,507.441,776,037.701,578,493.8325,947,271.26791,799.942,312,624.50-1,534,499.88
五、利润总额(元) -47,940,765.30-62,806,904.88-103,574,153.28-238,562,517.92-133,506,771.60-159,544,557.44-90,996,463.53
 减:所得税费用(元) 10,525,367.666,911,797.34-4,835,216.48-25,839,815.91-14,478,863.80-234,500.59-13,696,643.42
六、净利润(元) -58,466,132.96-69,718,702.22-98,738,936.80-212,722,702.01-119,027,907.80-159,310,056.85-77,299,820.11
(一)按经营持续性分类
  持续经营净利润(元) -58,466,132.96-69,718,702.22-98,738,936.80-212,722,702.01-119,027,907.80-159,310,056.85-77,299,820.11
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -59,606,057.81-61,297,206.85-98,919,578.18-212,722,702.01-119,027,907.80-159,310,056.85-77,299,820.11
  少数股东损益(元) 1,139,924.85-8,421,495.37180,641.38----
 扣除非经常性损益后的净利润(元) -61,556,709.46-63,459,853.64-124,119,343.08-197,700,579.34-125,631,868.01-147,301,095.89-168,900,155.36
七、每股收益
 一、基本每股收益(元) -0.06-0.06-0.10-0.21-0.12-0.15-0.08
 二、稀释每股收益(元) -0.06-0.06-0.10-0.22-0.12-0.15-0.08
八、其他综合收益(元) -42,561,050.70-15,301,057.9424,882,816.80-175,132,411.98-2,705,067.55186,044,432.08-61,212,648.44
 归属于母公司股东的其他综合收益(元) -34,345,113.29-15,821,628.7724,519,372.49-175,132,411.98-2,705,067.55186,044,432.08-61,212,648.44
 归属于少数股东的其他综合收益(元) -8,215,937.41520,570.83363,444.31----
九、综合收益总额(元) -101,027,183.66-85,019,760.16-73,856,120.00-387,855,113.99-121,732,975.3526,734,375.23-138,512,468.55
 归属于母公司所有者的综合收益总额(元) -93,951,171.10-77,118,835.62-74,400,205.69-387,855,113.99-121,732,975.3526,734,375.23-138,512,468.55
 归属于少数股东的综合收益总额(元) -7,076,012.56-7,900,924.54544,085.69----
公告日期 2024-10-302024-08-312024-04-272024-04-272023-10-312023-08-312023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院